LIDOCAINE HYDROCHLORIDE ANHYDROUS

LIDOCAINE HYDROCHLORIDE ANHYDROUS was reported 7046 times

These side effects are most commonly reported by patients taking LIDOCAINE HYDROCHLORIDE ANHYDROUS:

# Side effect Count
0 INFUSION SITE PAIN 792
1 NAUSEA 516
2 INFUSION SITE ERYTHEMA 494
3 DRUG INEFFECTIVE 488
4 HEADACHE 463
5 DYSPNOEA 452
6 DIARRHOEA 445
7 OFF LABEL USE 434
8 FATIGUE 394
9 PAIN 375
10 INFUSION SITE SWELLING 345
11 DIZZINESS 322
12 VOMITING 313
13 HYPOTENSION 243
14 INFUSION SITE HAEMORRHAGE 233
15 CARDIAC ARREST 194
16 MALAISE 193
17 PYREXIA 193
18 PNEUMONIA 190
19 PAIN IN EXTREMITY 186
20 ARTHRALGIA 173
21 THERAPY NON-RESPONDER 168
22 TOXICITY TO VARIOUS AGENTS 166
23 PRODUCT USE IN UNAPPROVED INDICATION 161
24 ASTHENIA 159
25 WEIGHT DECREASED 155
26 DRUG HYPERSENSITIVITY 154
27 BACK PAIN 150
28 COUGH 150
29 INFUSION SITE INFECTION 150
30 ANXIETY 148
31 DRUG INTERACTION 148
32 ANAEMIA 147
33 INFUSION SITE DISCHARGE 145
34 RASH 144
35 DECREASED APPETITE 138
36 DEVICE DISLOCATION 137
37 DEVICE INFUSION ISSUE 137
38 DEVICE ISSUE 136
39 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 136
40 INSOMNIA 134
41 ABDOMINAL PAIN 132
42 CONSTIPATION 131
43 HYPERTENSION 131
44 ANAPHYLACTIC SHOCK 127
45 CONDITION AGGRAVATED 127
46 PLATELET COUNT DECREASED 127
47 FEELING ABNORMAL 125
48 DEATH 120
49 FALL 117
50 OXYGEN SATURATION DECREASED 116
51 WEIGHT INCREASED 116
52 FEBRILE NEUTROPENIA 115
53 INFUSION SITE REACTION 113
54 INFUSION SITE INDURATION 112
55 DEVICE OCCLUSION 111
56 PRURITUS 111
57 BRADYCARDIA 110
58 DERMATITIS CONTACT 110
59 CHEST PAIN 109
60 DEVICE FAILURE 106
61 PALPITATIONS 106
62 INFUSION SITE PRURITUS 105
63 OVERDOSE 105
64 ERYTHEMA 103
65 ANAPHYLACTIC REACTION 102
66 MYALGIA 102
67 PERIPHERAL SWELLING 102
68 WHITE BLOOD CELL COUNT DECREASED 101
69 INFUSION SITE IRRITATION 100
70 INJECTION SITE PAIN 100
71 DEVICE MAINTENANCE ISSUE 98
72 PAIN IN JAW 98
73 PRODUCT USE ISSUE 96
74 LOSS OF CONSCIOUSNESS 95
75 SEIZURE 95
76 MIGRAINE 94
77 PRODUCT DOSE OMISSION ISSUE 92
78 DEVICE USE ERROR 91
79 ILLNESS 91
80 CONFUSIONAL STATE 90
81 DEVICE LEAKAGE 89
82 NASOPHARYNGITIS 88
83 TREMOR 88
84 CHILLS 87
85 OEDEMA PERIPHERAL 87
86 INFUSION SITE WARMTH 86
87 ABDOMINAL DISTENSION 85
88 HYPERSENSITIVITY 85
89 NEUTROPHIL COUNT DECREASED 85
90 HYPOKALAEMIA 84
91 BLOOD PRESSURE INCREASED 83
92 SOMNOLENCE 83
93 DEVICE MALFUNCTION 82
94 INFLUENZA 79
95 CHEST DISCOMFORT 77
96 HYPOXIA 77
97 SYNCOPE 77
98 HEART RATE INCREASED 76
99 TACHYCARDIA 76
100 ABDOMINAL DISCOMFORT 73
101 DRUG INTOLERANCE 73
102 THERAPY PARTIAL RESPONDER 73
103 CELLULITIS 72
104 HYPOAESTHESIA 72
105 DYSPNOEA EXERTIONAL 71
106 EPISTAXIS 70
107 FLUSHING 70
108 DEVICE POWER SOURCE ISSUE 69
109 ABDOMINAL PAIN UPPER 68
110 DEVICE WIRELESS COMMUNICATION ISSUE 68
111 DYSPHAGIA 68
112 URINARY TRACT INFECTION 68
113 BLOOD PRESSURE DECREASED 66
114 COVID-19 66
115 INFECTION 66
116 LYMPHOCYTE COUNT DECREASED 66
117 PURULENT DISCHARGE 66
118 DEVICE DIFFICULT TO USE 65
119 CONTUSION 64
120 POOR QUALITY SLEEP 64
121 INFUSION SITE NODULE 63
122 MUSCLE SPASMS 63
123 BURNING SENSATION 62
124 HYPERHIDROSIS 62
125 URTICARIA 62
126 CATARACT 60
127 FLUID RETENTION 60
128 SWELLING 60
129 DEPRESSION 59
130 GENERALISED TONIC-CLONIC SEIZURE 59
131 PARAESTHESIA 59
132 OEDEMA 58
133 NEUTROPENIA 57
134 STRESS 57
135 ACUTE KIDNEY INJURY 56
136 GAIT DISTURBANCE 56
137 ATRIAL FIBRILLATION 55
138 HERPES ZOSTER 55
139 HYPONATRAEMIA 55
140 INFUSION SITE DISCOLOURATION 55
141 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54
142 SINUSITIS 54
143 CARDIO-RESPIRATORY ARREST 53
144 PALLOR 53
145 PULMONARY HYPERTENSION 53
146 SEPSIS 53
147 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53
148 DEHYDRATION 52
149 GASTROINTESTINAL DISORDER 52
150 INFUSION SITE INFLAMMATION 52
151 MUSCULAR WEAKNESS 52
152 IMPAIRED QUALITY OF LIFE 51
153 MATERNAL EXPOSURE DURING PREGNANCY 51
154 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50
155 INFUSION SITE BRUISING 50
156 ALANINE AMINOTRANSFERASE INCREASED 49
157 BLISTER 49
158 ASPARTATE AMINOTRANSFERASE INCREASED 48
159 ASTHMA 48
160 DISCOMFORT 48
161 HAEMORRHOIDS 48
162 JOINT SWELLING 48
163 RESPIRATORY FAILURE 48
164 SKIN DISORDER 48
165 BODY TEMPERATURE INCREASED 47
166 DRY MOUTH 47
167 HYPERLIPIDAEMIA 47
168 HYPOCALCAEMIA 47
169 UNRESPONSIVE TO STIMULI 47
170 VISION BLURRED 47
171 MEDICATION ERROR 46
172 DYSPEPSIA 45
173 UNINTENTIONAL MEDICAL DEVICE REMOVAL 45
174 ACCIDENTAL OVERDOSE 44
175 DEVICE PHYSICAL PROPERTY ISSUE 44
176 DYSARTHRIA 44
177 EXPOSURE DURING PREGNANCY 44
178 HAEMOGLOBIN DECREASED 44
179 GASTROOESOPHAGEAL REFLUX DISEASE 43
180 IMPAIRED WORK ABILITY 43
181 INFUSION SITE DISCOMFORT 43
182 METHAEMOGLOBINAEMIA 43
183 PULMONARY ARTERIAL HYPERTENSION 43
184 DEVICE ALARM ISSUE 42
185 INFLUENZA LIKE ILLNESS 42
186 CEREBROVASCULAR ACCIDENT 41
187 CROHN^S DISEASE 41
188 VISUAL IMPAIRMENT 41
189 INFUSION SITE RASH 40
190 INTENTIONAL PRODUCT MISUSE 40
191 RESPIRATORY ARREST 40
192 RHINORRHOEA 40
193 THROMBOSIS 40
194 ACCIDENT 39
195 BLOOD GLUCOSE INCREASED 39
196 PRODUCT ADMINISTRATION INTERRUPTED 39
197 SEASONAL ALLERGY 39
198 STATUS EPILEPTICUS 39
199 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39
200 ARTHRITIS 38
201 CARDIOGENIC SHOCK 38
202 INCORRECT DOSE ADMINISTERED 38
203 NECK PAIN 38
204 PROCTALGIA 38
205 VENTRICULAR FIBRILLATION 38
206 CARDIAC FAILURE 37
207 DRUG ABUSE 37
208 MYELOSUPPRESSION 37
209 NEUROPATHY PERIPHERAL 37
210 ORAL HERPES 37
211 OROPHARYNGEAL PAIN 37
212 ACCIDENTAL EXPOSURE TO PRODUCT 36
213 ANAL INFLAMMATION 36
214 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36
215 THROMBOCYTOPENIA 36
216 BLOOD CREATININE INCREASED 35
217 BONE DENSITY DECREASED 35
218 DISTURBANCE IN ATTENTION 35
219 FOETAL DEATH 35
220 GASTROINTESTINAL HAEMORRHAGE 35
221 INFUSION SITE MASS 35
222 LEUKOPENIA 35
223 PLEURAL EFFUSION 35
224 BODY TINEA 34
225 C-REACTIVE PROTEIN INCREASED 34
226 DEPRESSED LEVEL OF CONSCIOUSNESS 34
227 EMOTIONAL DISTRESS 34
228 HYPERVOLAEMIA 34
229 MATERNAL EXPOSURE DURING DELIVERY 34
230 MEMORY IMPAIRMENT 34
231 MULTIPLE ORGAN DYSFUNCTION SYNDROME 34
232 MYDRIASIS 34
233 NEURALGIA 34
234 PRODUCT QUALITY ISSUE 34
235 PURPURA 34
236 ASCITES 33
237 COMA 33
238 DEVICE CONNECTION ISSUE 33
239 GENERAL PHYSICAL HEALTH DETERIORATION 33
240 GLUCOSE TOLERANCE IMPAIRED 33
241 HAEMOGLOBIN INCREASED 33
242 METABOLIC ACIDOSIS 33
243 PULMONARY EMBOLISM 33
244 SINUS TACHYCARDIA 33
245 STAPHYLOCOCCAL INFECTION 33
246 UPPER RESPIRATORY TRACT INFECTION 33
247 WHEEZING 33
248 BONE PAIN 32
249 INFECTION SUSCEPTIBILITY INCREASED 32
250 INHIBITORY DRUG INTERACTION 32
251 LIVE BIRTH 32
252 PRODUCT LEAKAGE 32
253 SARS-COV-2 TEST NEGATIVE 32
254 THERAPEUTIC RESPONSE DECREASED 32
255 VERTIGO 32
256 MENTAL STATUS CHANGES 31
257 PRODUCTIVE COUGH 31
258 PULMONARY OEDEMA 31
259 STRESS CARDIOMYOPATHY 31
260 AGITATION 30
261 HAEMORRHAGE 30
262 INTENTIONAL PRODUCT USE ISSUE 30
263 RASH PRURITIC 30
264 RENAL FAILURE 30
265 VENTRICULAR TACHYCARDIA 30
266 CARDIAC DISORDER 29
267 CONJUNCTIVITIS 29
268 HYPOAESTHESIA ORAL 29
269 STOMATITIS 29
270 APHASIA 28
271 BRONCHITIS 28
272 EYE PAIN 28
273 HOSPITALISATION 28
274 NASAL CONGESTION 28
275 PERICARDIAL EFFUSION 28
276 THROAT IRRITATION 28
277 TOXIC EPIDERMAL NECROLYSIS 28
278 CIRCULATORY COLLAPSE 27
279 CYSTITIS 27
280 DELIRIUM 27
281 DEVICE INFORMATION OUTPUT ISSUE 27
282 HYPERGLYCAEMIA 27
283 HYPERURICAEMIA 27
284 INFUSION SITE CELLULITIS 27
285 INJECTION SITE ERYTHEMA 27
286 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27
287 MOUTH ULCERATION 27
288 PREMATURE BABY 27
289 SEPTIC SHOCK 27
290 ACUTE RESPIRATORY FAILURE 26
291 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26
292 DEVICE ADHESION ISSUE 26
293 DIABETES MELLITUS 26
294 FEELING HOT 26
295 HYPERAESTHESIA 26
296 MUSCULOSKELETAL STIFFNESS 26
297 SHOCK 26
298 ALOPECIA 25
299 ALTERED STATE OF CONSCIOUSNESS 25
300 BLOOD CHOLESTEROL INCREASED 25
301 DEVICE PLACEMENT ISSUE 25
302 DIZZINESS POSTURAL 25
303 HEART RATE DECREASED 25
304 HEPATIC FUNCTION ABNORMAL 25
305 MOBILITY DECREASED 25
306 NEUROTOXICITY 25
307 GASTROENTERITIS VIRAL 24
308 HOT FLUSH 24
309 HYPOALBUMINAEMIA 24
310 MIOSIS 24
311 OSTEOARTHRITIS 24
312 RESPIRATORY DISTRESS 24
313 RESPIRATORY TRACT CONGESTION 24
314 SLEEP DISORDER 24
315 ARRHYTHMIA 23
316 HAEMOPTYSIS 23
317 HYPOPROTEINAEMIA 23
318 INFUSION SITE INJURY 23
319 OSTEOPOROSIS 23
320 OTITIS MEDIA 23
321 RESTLESSNESS 23
322 TREATMENT NONCOMPLIANCE 23
323 APNOEA 22
324 BACTERIAL INFECTION 22
325 BALANCE DISORDER 22
326 DYSKINESIA 22
327 DYSPHONIA 22
328 FOREIGN BODY 22
329 HEMIPARESIS 22
330 INJECTION SITE REACTION 22
331 KOUNIS SYNDROME 22
332 REMOVAL OF FOREIGN BODY 22
333 SKIN EXFOLIATION 22
334 TREATMENT FAILURE 22
335 WHITE BLOOD CELL COUNT INCREASED 22
336 ELECTROCARDIOGRAM QT PROLONGED 21
337 HALLUCINATION 21
338 INTESTINAL OBSTRUCTION 21
339 MALIGNANT NEOPLASM PROGRESSION 21
340 MASTOIDITIS 21
341 OBSTRUCTIVE AIRWAYS DISORDER 21
342 PARAESTHESIA ORAL 21
343 RASH MACULO-PAPULAR 21
344 SUPRAVENTRICULAR TACHYCARDIA 21
345 TINNITUS 21
346 AMNESIA 20
347 ANGINA PECTORIS 20
348 DEPRESSED MOOD 20
349 DEVICE BREAKAGE 20
350 INJURY 20
351 LETHARGY 20
352 PANIC ATTACK 20
353 PARANASAL CYST 20
354 RENAL IMPAIRMENT 20
355 RHEUMATOID ARTHRITIS 20
356 SINUS DISORDER 20
357 SNEEZING 20
358 SPEECH DISORDER 20
359 URINARY RETENTION 20
360 VASCULAR MALFORMATION 20
361 BLOOD POTASSIUM DECREASED 19
362 CATHETER SITE ERYTHEMA 19
363 DISORIENTATION 19
364 FOETAL EXPOSURE DURING PREGNANCY 19
365 HYPOPHAGIA 19
366 HYPOPHOSPHATAEMIA 19
367 INJECTION SITE SWELLING 19
368 LUNG DISORDER 19
369 PHRENIC NERVE PARALYSIS 19
370 POISONING 19
371 PRODUCT PACKAGING CONFUSION 19
372 VISUAL ACUITY REDUCED 19
373 WITHDRAWAL SYNDROME 19
374 ADVERSE EVENT 18
375 ANAESTHETIC COMPLICATION 18
376 APPENDICITIS 18
377 BLOOD BILIRUBIN INCREASED 18
378 BRONCHOSPASM 18
379 DEVICE KINK 18
380 DRUG ERUPTION 18
381 EATING DISORDER 18
382 FOREIGN BODY IN RESPIRATORY TRACT 18
383 INCORRECT DRUG ADMINISTRATION RATE 18
384 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 18
385 IRRITABILITY 18
386 MOTOR DYSFUNCTION 18
387 MUSCLE TWITCHING 18
388 NEUTROPHIL COUNT INCREASED 18
389 RASH MACULAR 18
390 TOOTHACHE 18
391 TOXIC ANTERIOR SEGMENT SYNDROME 18
392 TRACHEAL DEVIATION 18
393 CHOLELITHIASIS 17
394 DEVICE USE ISSUE 17
395 DIPLOPIA 17
396 FUNGAL INFECTION 17
397 HYPERPHOSPHATAEMIA 17
398 INFUSION SITE VESICLES 17
399 INJECTION SITE HAEMORRHAGE 17
400 INSPIRATORY CAPACITY DECREASED 17
401 LIVER INJURY 17
402 OXYGEN CONSUMPTION INCREASED 17
403 PANCYTOPENIA 17
404 RASH ERYTHEMATOUS 17
405 SKIN DISCOLOURATION 17
406 SLEEP APNOEA SYNDROME 17
407 URINARY INCONTINENCE 17
408 ANGIOEDEMA 16
409 ARTHRITIS BACTERIAL 16
410 BENIGN PROSTATIC HYPERPLASIA 16
411 CARDIAC FAILURE CONGESTIVE 16
412 CHRONIC KIDNEY DISEASE 16
413 COGNITIVE DISORDER 16
414 COLD SWEAT 16
415 CONVULSION 16
416 DYSURIA 16
417 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16
418 GINGIVAL PAIN 16
419 HYPERSOMNIA 16
420 HYPERTHERMIA MALIGNANT 16
421 HYPOACUSIS 16
422 HYPOMAGNESAEMIA 16
423 INJECTION SITE BRUISING 16
424 LIP SWELLING 16
425 PATIENT DISSATISFACTION WITH DEVICE 16
426 PRESYNCOPE 16
427 PULSE ABSENT 16
428 RETCHING 16
429 SEROTONIN SYNDROME 16
430 SINUS CONGESTION 16
431 ACUTE RESPIRATORY DISTRESS SYNDROME 15
432 BLOOD PHOSPHORUS INCREASED 15
433 BLOOD UREA INCREASED 15
434 BRAIN FOG 15
435 DRUG USE DISORDER 15
436 EXPIRED PRODUCT ADMINISTERED 15
437 FEELING COLD 15
438 HICCUPS 15
439 IMMUNE THROMBOCYTOPENIA 15
440 INCREASED APPETITE 15
441 INTERSTITIAL LUNG DISEASE 15
442 LIMB DISCOMFORT 15
443 LIMB INJURY 15
444 LIVER FUNCTION TEST INCREASED 15
445 MENTAL DISORDER 15
446 MUSCULOSKELETAL CHEST PAIN 15
447 MUSCULOSKELETAL DISORDER 15
448 MYASTHENIA GRAVIS 15
449 NERVOUSNESS 15
450 PNEUMOTHORAX 15
451 PRODUCT ADHESION ISSUE 15
452 QUALITY OF LIFE DECREASED 15
453 RESPIRATORY TRACT INFECTION 15
454 RESTLESS LEGS SYNDROME 15
455 SENSORY LOSS 15
456 SUDDEN DEATH 15
457 TACHYPNOEA 15
458 THROAT TIGHTNESS 15
459 VASCULAR DEVICE INFECTION 15
460 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15
461 ABNORMAL BEHAVIOUR 14
462 BLINDNESS 14
463 BLOOD ALBUMIN DECREASED 14
464 BLOOD URIC ACID INCREASED 14
465 CATHETER SITE HAEMORRHAGE 14
466 DISEASE PROGRESSION 14
467 DRUG TITRATION ERROR 14
468 DYSGEUSIA 14
469 EAR INFECTION 14
470 EXTRA DOSE ADMINISTERED 14
471 EYE IRRITATION 14
472 FACIAL PARALYSIS 14
473 FOETAL EXPOSURE DURING DELIVERY 14
474 GENITAL EROSION 14
475 HAEMATURIA 14
476 INTRAOCULAR PRESSURE INCREASED 14
477 LYMPHADENOPATHY 14
478 MATERNAL EXPOSURE TIMING UNSPECIFIED 14
479 MUCOSAL EROSION 14
480 MYOCARDIAL INFARCTION 14
481 PARALYSIS 14
482 POST PROCEDURAL COMPLICATION 14
483 PSORIASIS 14
484 RHABDOMYOLYSIS 14
485 SPINAL OSTEOARTHRITIS 14
486 SUICIDAL IDEATION 14
487 TASTE DISORDER 14
488 VIRAL INFECTION 14
489 WEIGHT FLUCTUATION 14
490 ADVERSE DRUG REACTION 13
491 APPENDICOLITH 13
492 ARTERIAL OCCLUSIVE DISEASE 13
493 CATHETER SITE PAIN 13
494 CONTRAINDICATED PRODUCT ADMINISTERED 13
495 CYANOSIS 13
496 CYTOKINE RELEASE SYNDROME 13
497 DERMATITIS ALLERGIC 13
498 DRUG LEVEL INCREASED 13
499 FULL BLOOD COUNT ABNORMAL 13
500 HAEMATOCRIT DECREASED 13
501 INFLAMMATION 13
502 INJECTION SITE INFLAMMATION 13
503 MUSCLE SPASTICITY 13
504 NEEDLE ISSUE 13
505 NERVE INJURY 13
506 NIGHT SWEATS 13
507 PANCREATITIS 13
508 PNEUMONITIS 13
509 PROCEDURAL PAIN 13
510 PRODUCT ADMINISTRATION ERROR 13
511 PROTEIN TOTAL DECREASED 13
512 PSYCHOMOTOR HYPERACTIVITY 13
513 RESPIRATORY ACIDOSIS 13
514 RESPIRATORY DEPRESSION 13
515 SALIVARY HYPERSECRETION 13
516 SENSITIVE SKIN 13
517 SKIN HAEMORRHAGE 13
518 SKIN NECROSIS 13
519 SPINAL PAIN 13
520 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13
521 SWELLING FACE 13
522 TORSADE DE POINTES 13
523 UNEVALUABLE DEVICE ISSUE 13
524 UNEVALUABLE EVENT 13
525 WOUND 13
526 ACUTE MYOCARDIAL INFARCTION 12
527 ARTHROPATHY 12
528 BLOOD ALKALINE PHOSPHATASE INCREASED 12
529 BLOOD SODIUM DECREASED 12
530 CRYING 12
531 DEEP VEIN THROMBOSIS 12
532 DRY SKIN 12
533 EYE MOVEMENT DISORDER 12
534 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
535 GLAUCOMA 12
536 HAEMATOCHEZIA 12
537 HEAD INJURY 12
538 HEMIPLEGIA 12
539 HYPERKALAEMIA 12
540 HYPERTONIA 12
541 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 12
542 INFUSION SITE ABSCESS 12
543 INFUSION SITE SCAR 12
544 INTERVERTEBRAL DISC PROTRUSION 12
545 JOINT INJURY 12
546 LIVER DISORDER 12
547 PROCEDURAL HYPOTENSION 12
548 RESPIRATORY DISORDER 12
549 SUBSTANCE ABUSE 12
550 SUBSTANCE USE DISORDER 12
551 THERAPEUTIC PRODUCT EFFECT DECREASED 12
552 TOOTH DISORDER 12
553 TRICUSPID VALVE INCOMPETENCE 12
554 APHONIA 11
555 ARTERIOSCLEROSIS CORONARY ARTERY 11
556 ARTHRITIS INFECTIVE 11
557 ASPIRATION 11
558 ATELECTASIS 11
559 BLOOD GLUCOSE DECREASED 11
560 BLOOD LACTIC ACID INCREASED 11
561 CANDIDA INFECTION 11
562 DRUG DEPENDENCE 11
563 ECZEMA 11
564 EMBOLIA CUTIS MEDICAMENTOSA 11
565 EYELID PTOSIS 11
566 FEAR 11
567 FEEDING DISORDER 11
568 HEPATIC ENZYME INCREASED 11
569 ILEUS 11
570 INFUSION SITE EXTRAVASATION 11
571 INJECTION SITE INFECTION 11
572 LACERATION 11
573 LOW DENSITY LIPOPROTEIN INCREASED 11
574 MUCOSAL INFLAMMATION 11
575 NEPHROLITHIASIS 11
576 NO ADVERSE EVENT 11
577 NYSTAGMUS 11
578 PROCEDURAL COMPLICATION 11
579 RED BLOOD CELL COUNT DECREASED 11
580 RENAL DISORDER 11
581 RIGHT VENTRICULAR FAILURE 11
582 SKIN BURNING SENSATION 11
583 SULPHAEMOGLOBINAEMIA 11
584 SUPRAVENTRICULAR EXTRASYSTOLES 11
585 THERAPEUTIC RESPONSE UNEXPECTED 11
586 THERAPY INTERRUPTED 11
587 WRONG PRODUCT ADMINISTERED 11
588 ACCIDENTAL DEATH 10
589 AFFECT LABILITY 10
590 ANAL ABSCESS 10
591 BACTERAEMIA 10
592 BLOOD CALCIUM DECREASED 10
593 BLOOD PHOSPHORUS DECREASED 10
594 BLOOD TEST ABNORMAL 10
595 BLOOD TRIGLYCERIDES INCREASED 10
596 BUNDLE BRANCH BLOCK LEFT 10
597 CATHETER SITE SWELLING 10
598 COORDINATION ABNORMAL 10
599 CYTOMEGALOVIRUS INFECTION 10
600 DEVICE ELECTRICAL FINDING 10
601 DEVICE RELATED INFECTION 10
602 DISSEMINATED INTRAVASCULAR COAGULATION 10
603 DRY EYE 10
604 ENCEPHALOPATHY 10
605 EXPOSURE VIA SKIN CONTACT 10
606 FLATULENCE 10
607 FULL BLOOD COUNT DECREASED 10
608 GANGRENE 10
609 HYPOGLYCAEMIA 10
610 IMPAIRED GASTRIC EMPTYING 10
611 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
612 INFUSION RELATED REACTION 10
613 INFUSION SITE OEDEMA 10
614 INFUSION SITE SCAB 10
615 MALNUTRITION 10
616 MOUTH HAEMORRHAGE 10
617 MUSCULOSKELETAL DISCOMFORT 10
618 MUSCULOSKELETAL PAIN 10
619 NEUROLOGIC NEGLECT SYNDROME 10
620 OSTEONECROSIS OF JAW 10
621 OSTEOPENIA 10
622 PELVIC PAIN 10
623 PERSONALITY DISORDER 10
624 POLYURIA 10
625 PRODUCT PREPARATION ERROR 10
626 RECTAL HAEMORRHAGE 10
627 RESPIRATORY RATE INCREASED 10
628 SINUS BRADYCARDIA 10
629 SLEEP DEFICIT 10
630 SMALL INTESTINAL OBSTRUCTION 10
631 SWOLLEN TONGUE 10
632 TRANSIENT ISCHAEMIC ATTACK 10
633 TRISMUS 10
634 VENTRICULAR EXTRASYSTOLES 10
635 VITREOUS HAEMORRHAGE 10
636 ADJUSTMENT DISORDER 9
637 ANAESTHETIC COMPLICATION NEUROLOGICAL 9
638 ANALGESIC THERAPY 9
639 APPLICATION SITE PAIN 9
640 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9
641 BLOOD CREATINE PHOSPHOKINASE INCREASED 9
642 BLOOD LACTATE DEHYDROGENASE INCREASED 9
643 BONE DISORDER 9
644 BREAST CANCER 9
645 CAROTID ARTERY THROMBOSIS 9
646 CARPAL TUNNEL SYNDROME 9
647 CATHETER SITE DISCHARGE 9
648 CHEMICAL BURN 9
649 COVID-19 PNEUMONIA 9
650 DRUG TOLERANCE DECREASED 9
651 ENDOPHTHALMITIS 9
652 GAIT INABILITY 9
653 GASTRITIS 9
654 GOUT 9
655 GROIN PAIN 9
656 HEPATIC FAILURE 9
657 HIATUS HERNIA 9
658 HIP FRACTURE 9
659 HYPERTRIGLYCERIDAEMIA 9
660 INFANTILE APNOEA 9
661 INFUSION SITE URTICARIA 9
662 INJECTION SITE PRURITUS 9
663 IRON DEFICIENCY 9
664 LABORATORY TEST ABNORMAL 9
665 LARYNGEAL OEDEMA 9
666 LOCALISED INFECTION 9
667 NEOPLASM MALIGNANT 9
668 NERVOUS SYSTEM DISORDER 9
669 OCULAR HYPERAEMIA 9
670 ORAL PAIN 9
671 POST HERPETIC NEURALGIA 9
672 PREMATURE DELIVERY 9
673 PRODUCT PRESCRIBING ERROR 9
674 PROSTATIC PAIN 9
675 PSYCHOTIC DISORDER 9
676 ROAD TRAFFIC ACCIDENT 9
677 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9
678 STEVENS-JOHNSON SYNDROME 9
679 SURGERY 9
680 SUSPECTED OFF LABEL USE 9
681 SYSTEMIC LUPUS ERYTHEMATOSUS 9
682 TONGUE SPASM 9
683 TYPE 2 DIABETES MELLITUS 9
684 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8
685 ACUTE MACULAR NEURORETINOPATHY 8
686 ADMINISTRATION RELATED REACTION 8
687 ANHEDONIA 8
688 BILIRUBIN CONJUGATED INCREASED 8
689 BLINDNESS TRANSIENT 8
690 BLOOD PRESSURE ABNORMAL 8
691 BLOOD PRESSURE SYSTOLIC INCREASED 8
692 BLOOD SODIUM INCREASED 8
693 BONE LESION 8
694 BONE MARROW FAILURE 8
695 CANCER PAIN 8
696 CARDIOMEGALY 8
697 CATHETER SITE IRRITATION 8
698 CAUDA EQUINA SYNDROME 8
699 CENTRAL PAIN SYNDROME 8
700 CEREBRAL HAEMORRHAGE FOETAL 8
701 CLONUS 8
702 COLITIS 8
703 COMPLETED SUICIDE 8
704 COMPLICATION ASSOCIATED WITH DEVICE 8
705 DEVICE DELIVERY SYSTEM ISSUE 8
706 DRUG-INDUCED LIVER INJURY 8
707 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 8
708 ELECTROLYTE IMBALANCE 8
709 EPILEPSY 8
710 EXTRADURAL ABSCESS 8
711 EYE INFLAMMATION 8
712 GASTRIC ULCER 8
713 GENERALISED OEDEMA 8
714 GINGIVAL BLEEDING 8
715 GRAND MAL CONVULSION 8
716 HAEMATEMESIS 8
717 HAEMOLYSIS 8
718 HAEMORRHAGE INTRACRANIAL 8
719 HALLUCINATION, VISUAL 8
720 HEAD DISCOMFORT 8
721 HORNER^S SYNDROME 8
722 HYPERCAPNIA 8
723 IMPAIRED HEALING 8
724 INCONTINENCE 8
725 INJECTION SITE IRRITATION 8
726 IRON DEFICIENCY ANAEMIA 8
727 LACRIMATION INCREASED 8
728 LEFT VENTRICULAR DYSFUNCTION 8
729 LOCALISED OEDEMA 8
730 MENINGITIS ASEPTIC 8
731 METASTASES TO BONE 8
732 MOUTH SWELLING 8
733 MYOCLONUS 8
734 NEOPLASM PROGRESSION 8
735 NEUROLOGICAL SYMPTOM 8
736 PHARYNGEAL SWELLING 8
737 PNEUMOCEPHALUS 8
738 PRODUCT DISPENSING ERROR 8
739 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8
740 PRODUCT LABEL CONFUSION 8
741 PROTEIN URINE PRESENT 8
742 PUPILLARY REFLEX IMPAIRED 8
743 RASH PAPULAR 8
744 RETINAL ARTERY OCCLUSION 8
745 RETINAL DETACHMENT 8
746 SCHIZENCEPHALY 8
747 SCIATICA 8
748 SEDATION 8
749 SKIN ULCER 8
750 SUICIDE ATTEMPT 8
751 SUSPECTED PRODUCT CONTAMINATION 8
752 SYNOVITIS 8
753 TOOTH INFECTION 8
754 ULCER 8
755 VAGINAL HAEMORRHAGE 8
756 VITREOUS FLOATERS 8
757 VOMITING PROJECTILE 8
758 APPLICATION SITE ERYTHEMA 7
759 ATRIOVENTRICULAR BLOCK 7
760 BLOOD BLISTER 7
761 BLOOD CHLORIDE DECREASED 7
762 BRAIN OEDEMA 7
763 BRAIN STEM SYNDROME 7
764 BURSITIS 7
765 CEREBRAL INFARCTION 7
766 CHROMATURIA 7
767 COLITIS ULCERATIVE 7
768 DEAFNESS 7
769 DEAFNESS NEUROSENSORY 7
770 DEAFNESS UNILATERAL 7
771 DECREASED ACTIVITY 7
772 DEVICE LOOSENING 7
773 DUODENAL ULCER 7
774 DYSTONIA 7
775 EOSINOPHILIA 7
776 ERUCTATION 7
777 EYE DISORDER 7
778 EYE INFECTION 7
779 EYE SWELLING 7
780 FEELING OF BODY TEMPERATURE CHANGE 7
781 FIBROMYALGIA 7
782 FOOD INTERACTION 7
783 GASTROINTESTINAL MOTILITY DISORDER 7
784 GLYCOSYLATED HAEMOGLOBIN INCREASED 7
785 HAEMODYNAMIC INSTABILITY 7
786 HEART RATE IRREGULAR 7
787 HEPATIC CIRRHOSIS 7
788 HEPATIC STEATOSIS 7
789 HOIGNE^S SYNDROME 7
790 HYPERTENSIVE CRISIS 7
791 HYPERTRANSAMINASAEMIA 7
792 HYPOKINESIA 7
793 HYPOTHYROIDISM 7
794 HYPOTONIA 7
795 INCORRECT PRODUCT ADMINISTRATION DURATION 7
796 INFUSION SITE HYPERSENSITIVITY 7
797 INFUSION SITE STREAKING 7
798 INTRACRANIAL PRESSURE INCREASED 7
799 JOINT EFFUSION 7
800 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7
801 LACUNAR INFARCTION 7
802 LIPASE INCREASED 7
803 LIVER FUNCTION TEST ABNORMAL 7
804 LUNG INFECTION 7
805 MASS 7
806 MOVEMENT DISORDER 7
807 MUSCLE ATROPHY 7
808 MUSCLE TIGHTNESS 7
809 NEUTROPHILIA 7
810 NORMAL NEWBORN 7
811 OXYGEN SATURATION ABNORMAL 7
812 OXYGEN THERAPY 7
813 PANCREATITIS ACUTE 7
814 PARAPLEGIA 7
815 PHARYNGEAL OEDEMA 7
816 PNEUMONIA BACTERIAL 7
817 POOR QUALITY DRUG ADMINISTERED 7
818 PRODUCT CONTAMINATION PHYSICAL 7
819 PRODUCT PRESCRIBING ISSUE 7
820 PRODUCT STORAGE ERROR 7
821 PULMONARY MASS 7
822 PYELONEPHRITIS 7
823 RENAL CYST 7
824 SKIN ABRASION 7
825 SKIN INFECTION 7
826 SKIN IRRITATION 7
827 SLEEP DISORDER THERAPY 7
828 SUBDURAL HAEMATOMA 7
829 TRANSAMINASES INCREASED 7
830 ABNORMAL SENSATION IN EYE 6
831 ABSCESS 6
832 AUTOIMMUNE DISORDER 6
833 BLEPHAROSPASM 6
834 BLOOD CHOLINESTERASE DECREASED 6
835 BLOOD MAGNESIUM DECREASED 6
836 BLOOD POTASSIUM INCREASED 6
837 BLOOD PRESSURE FLUCTUATION 6
838 BRONCHOPULMONARY ASPERGILLOSIS 6
839 BUNDLE BRANCH BLOCK RIGHT 6
840 CARDIOTOXICITY 6
841 CLOSTRIDIUM DIFFICILE INFECTION 6
842 CONSCIOUSNESS FLUCTUATING 6
843 CYTOPENIA 6
844 DEMENTIA 6
845 DIABETES MELLITUS INADEQUATE CONTROL 6
846 DIABETIC KETOACIDOSIS 6
847 DIABETIC NEUROPATHY 6
848 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6
849 DRUG THERAPY 6
850 DRUG TOXICITY 6
851 DRUG-DISEASE INTERACTION 6
852 EAR PAIN 6
853 EMPHYSEMA 6
854 END STAGE RENAL DISEASE 6
855 ENDOCARDITIS 6
856 ENTERITIS 6
857 EXERCISE TOLERANCE DECREASED 6
858 EYE HAEMORRHAGE 6
859 FEMUR FRACTURE 6
860 FINE MOTOR SKILL DYSFUNCTION 6
861 FOOT FRACTURE 6
862 GALLBLADDER DISORDER 6
863 GASTROINTESTINAL PAIN 6
864 GLOBULINS DECREASED 6
865 HAEMATOMA 6
866 HALLUCINATION, AUDITORY 6
867 HEAVY MENSTRUAL BLEEDING 6
868 HEPATOMEGALY 6
869 HYPERCALCAEMIA 6
870 HYPERPYREXIA 6
871 HYPOCHLORAEMIA 6
872 HYPOVOLAEMIA 6
873 INFUSION SITE DRYNESS 6
874 INJECTION SITE MASS 6
875 INJECTION SITE VESICLES 6
876 INSURANCE ISSUE 6
877 INTERNATIONAL NORMALISED RATIO INCREASED 6
878 IRRITABLE BOWEL SYNDROME 6
879 JOINT INSTABILITY 6
880 LOWER RESPIRATORY TRACT INFECTION 6
881 MACULAR HOLE 6
882 MECHANICAL URTICARIA 6
883 MELAENA 6
884 MULTIPLE ALLERGIES 6
885 NASAL DISCOMFORT 6
886 NEOPLASM 6
887 OCULAR DISCOMFORT 6
888 OESOPHAGITIS 6
889 OPEN FRACTURE 6
890 ORAL CANDIDIASIS 6
891 ORAL DISCOMFORT 6
892 PAINFUL EJACULATION 6
893 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 6
894 PERINEAL PAIN 6
895 PERIPHERAL COLDNESS 6
896 PHARYNGITIS 6
897 PHOTOPHOBIA 6
898 PHOTOPSIA 6
899 PLATELET COUNT INCREASED 6
900 PNEUMONIA ASPIRATION 6
901 PNEUMONIA FUNGAL 6
902 POLLAKIURIA 6
903 PSEUDOMONAS INFECTION 6
904 RALES 6
905 RENAL FAILURE ACUTE 6
906 RENAL TUBULAR NECROSIS 6
907 RESPIRATION ABNORMAL 6
908 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6
909 RESPIRATORY TRACT INFECTION VIRAL 6
910 RIB FRACTURE 6
911 SCAR 6
912 SCOLIOSIS 6
913 SECRETION DISCHARGE 6
914 SELF-MEDICATION 6
915 SENSORY DISTURBANCE 6
916 SKIN LACERATION 6
917 SPINAL COMPRESSION FRACTURE 6
918 SPINAL CORD INFARCTION 6
919 STRIDOR 6
920 SUBARACHNOID HAEMORRHAGE 6
921 TONGUE HAEMORRHAGE 6
922 TONGUE INJURY 6
923 TONGUE MOVEMENT DISTURBANCE 6
924 TOOTH ABSCESS 6
925 TRIGEMINO-CARDIAC REFLEX 6
926 UPPER GASTROINTESTINAL HAEMORRHAGE 6
927 VITAMIN D DEFICIENCY 6
928 ABORTION INDUCED 5
929 ACNE 5
930 ACUTE PULMONARY OEDEMA 5
931 ADMINISTRATION SITE ODOUR 5
932 ADRENAL INSUFFICIENCY 5
933 ADULTERATED PRODUCT 5
934 ADVERSE REACTION 5
935 AGRANULOCYTOSIS 5
936 ANAL INCONTINENCE 5
937 ANAPHYLACTOID REACTION 5
938 ANAPHYLACTOID SHOCK 5
939 ANKLE FRACTURE 5
940 ASPHYXIA 5
941 ATAXIA 5
942 BACK DISORDER 5
943 BACK INJURY 5
944 BILE ACIDS INCREASED 5
945 BLOOD CALCIUM INCREASED 5
946 BLOOD PH DECREASED 5
947 BLOOD PRESSURE IMMEASURABLE 5
948 BLOOD URINE PRESENT 5
949 BRAIN DEATH 5
950 BRAIN NATRIURETIC PEPTIDE INCREASED 5
951 CACHEXIA 5
952 CANDIDA ENDOPHTHALMITIS 5
953 CARDIOVASCULAR DISORDER 5
954 CARDIOVASCULAR INSUFFICIENCY 5
955 CATHETER SITE PRURITUS 5
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5
957 COLITIS ISCHAEMIC 5
958 CONDUCTION DISORDER 5
959 CORNEAL OEDEMA 5
960 CRANIOCEREBRAL INJURY 5
961 CUSHING^S SYNDROME 5
962 CYSTOID MACULAR OEDEMA 5
963 DEAFNESS BILATERAL 5
964 DELUSION 5
965 DEVICE USE CONFUSION 5
966 DISEASE RECURRENCE 5
967 DROOLING 5
968 DRUG EFFECT DECREASED 5
969 DYSCHEZIA 5
970 EAR DISCOMFORT 5
971 ELECTROCARDIOGRAM ABNORMAL 5
972 ENDOTRACHEAL INTUBATION 5
973 ENTEROCOCCAL INFECTION 5
974 ENTEROCOLITIS 5
975 ESCHERICHIA INFECTION 5
976 EYE PRURITUS 5
977 FACIAL SPASM 5
978 FIBRIN D DIMER INCREASED 5
979 FLANK PAIN 5
980 GAZE PALSY 5
981 GLOMERULAR FILTRATION RATE DECREASED 5
982 HEPATIC ENCEPHALOPATHY 5
983 HYPERNATRAEMIA 5
984 HYPERTHYROIDISM 5
985 HYPERVENTILATION 5
986 HYPOGAMMAGLOBULINAEMIA 5
987 HYPOGLYCAEMIC COMA 5
988 HYPOTONIA NEONATAL 5
989 IMMUNE SYSTEM DISORDER 5
990 IMMUNODEFICIENCY 5
991 INCORRECT PRODUCT FORMULATION ADMINISTERED 5
992 INFUSION SITE HAEMATOMA 5
993 INJECTION SITE DISCHARGE 5
994 INJECTION SITE WARMTH 5
995 INTENTIONAL OVERDOSE 5
996 LEUKOCYTOSIS 5
997 LOWER LIMB FRACTURE 5
998 LUMBAR SPINAL STENOSIS 5
999 LUNG INFILTRATION 5